Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126227971 | 12622797 | 1 | I | 20160720 | 20160804 | 20160804 | EXP | 000667078 | CA-HQ SPECIALTY-CA-2016INT000668 | INTERCHEM | 41.00 | YR | F | Y | 0.00000 | 20160804 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126227971 | 12622797 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | 2.857 MG,(20 MG,1 IN 1 W) | U | 201749 | 2.857 | MG | |||||||
| 126227971 | 12622797 | 2 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 7.142 MG, (50 MG,1 IN 1 W) | U | 0 | 7.142 | MG | |||||||
| 126227971 | 12622797 | 3 | SS | CELEBREX | CELECOXIB | 1 | Unknown | UNK | U | 0 | |||||||||
| 126227971 | 12622797 | 4 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126227971 | 12622797 | 5 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | 20 MG, (20 MG,1 IN 1 D) | U | 0 | 20 | MG | ||||||||
| 126227971 | 12622797 | 6 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | 400 MG, (200 MG, 2 IN 1 D) | U | 0 | 200 | MG | ||||||||
| 126227971 | 12622797 | 7 | SS | SIMPONI | GOLIMUMAB | 1 | Subcutaneous | CYCLICAL, (50 MG) | U | 0 | 50 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126227971 | 12622797 | 1 | Rheumatoid arthritis |
| 126227971 | 12622797 | 2 | Rheumatoid arthritis |
| 126227971 | 12622797 | 3 | Arthritis |
| 126227971 | 12622797 | 4 | Rheumatoid arthritis |
| 126227971 | 12622797 | 5 | Product used for unknown indication |
| 126227971 | 12622797 | 6 | Rheumatoid arthritis |
| 126227971 | 12622797 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126227971 | 12622797 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126227971 | 12622797 | Activities of daily living impaired | |
| 126227971 | 12622797 | Malaise | |
| 126227971 | 12622797 | Migraine | |
| 126227971 | 12622797 | Nausea | |
| 126227971 | 12622797 | Rheumatoid arthritis | |
| 126227971 | 12622797 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |